TABLE 1

Baseline characteristics for clamp study cohort

Type 1 diabetes (n = 40)Controls (n = 47)P
Age (years)45.2 ± 9.245.9 ± 7.20.7
Male/female19/2120/27
Duration of diabetes (years)22.6 ± 7.8
GHb (%)7.5 ± 0.95.4 ± 0.3<0.0001
Fasting glucose (mg/dl)116 ± 3996 ± 80.0024
Body fat (%)28.6 ± 7.529.6 ± 7.10.53
BMI (kg/m2)27.0 ± 4.426.0 ± 4.10.31
Visceral fat area (cm2)72.7 ± 50.580.5 ± 50.50.49
Subcutaneous fat area (cm2)271 ± 126273 ± 1120.97
Sagittal diameter (mm)214 ± 36214 ± 310.96
Waist circumference (cm)88.5 ± 12.386.3 ± 12.40.42
Waist:hip ratio0.84 ± 0.080.83 ± 0.090.44
Liver:spleen density ratio1.26 ± 0.081.24 ± 0.240.58
Total cholesterol (mg/dl)139.9 ± 32.4171.1 ± 28.8<0.0001
HDL cholesterol (mg/dl)58.0 ± 22.453.4 ± 15.00.27
Triglycerides (mg/dl)69.7 ± 33.8108.0 ± 57.20.0002
LDL cholesterol (mg/dl)67.6 ± 24.896.1 ± 26.0<0.0001
Systolic blood pressure (mmHg)114 ± 11113 ± 100.61
Diastolic blood pressure (mmHg)73 ± 776 ± 80.09
On hypertension medications (%)45130.0005
Habitual physical activity (log kcal)7.2 ± 1.27.4 ± 7.10.42
Adiponection (geometric mean ± SD)10.9 ± 1.78.2 ± 1.80.02
Cortisol (μg/dl)11.8 ± 4.311.5 ± 4.40.8
  • Values are unadjusted mean ± SD except where otherwise indicated.